Robert Caccese - Concepedia

Author

Robert Caccese

Also Known As

Caccese, Robert, R Caccese, R G Caccese, R. Caccese, R. G. Caccese, R.G. Caccese, ROBERT G. CACCESE, Robert Caccese, Robert G. Caccese

Publications

505

Citations

H-Index

Concepts

All Affiliations

Princeton University Wilmington University AstraZeneca (United States)

About

Robert Caccese is an author at Princeton University specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	353
2	Natural Sciences	2	2	41
3	Biochemistry	2	2	41
4	Health Sciences	1	1	20
5	Public Health	1	1	14

Robert Caccese

Publications

468

Citations

H-Index

Page 1

	Year	Citations
Interleukin-1 stimulates the secretion of proteoglycan- and collagen-degrading proteases by rabbit articular chondrocytes Richard D. Pasternak, Stephen J. Hubbs, Robert Caccese, Clinical Immunology and Immunopathology InflammationRheumatologyCytokineAutoimmune DiseaseRabbit Articular Chondrocytes	1986	60
Effects of Orally Administered Rapamycin in Animal Models of Arthritis and Other Autoimmune Diseases Richard P. Carlson, William L. Baeder, Robert Caccese, Annals of the New York Academy of Sciences InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune Disease	1993	55
Preclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid Receptor Thomas J. Hudzik, Carla Maciag, Mark A. Smith, Journal of Pharmacology and Experimental Therapeutics	2011	54
Bacterial lipopolysaccharide potentiates type II collagen‐induced arthritis in mice Robert Caccese, John Zimmerman, Richard P. Carlson Mediators of Inflammation Cia MiceImmunologyType IiInflammatory ArthritisInflammation	1992	48
Proteoglycan- and Collagen-Degrading Enzymes from Human Interleukin 1-Stimulated Chondrocytes from Several Species: Proteoglycanase and Collagenase Inhibitors as Potentially New Disease-Modifying Antiarthritic Agents G. DiPasquale, Robert Caccese, Richard D. Pasternak, Experimental Biology and Medicine Collagenase InhibitorsImmunologyPathologyBiological TherapyMusculoskeletal Research	1986	40
Assessment of Biomarkers of Drug-Induced Kidney Injury in Cynomolgus Monkeys Treated with a Triple Reuptake Inhibitor Mausumee Guha, Annabelle Heier, Sally Price, Toxicological Sciences Diki BiomarkersPharmacotherapyExperimental PharmacologyRenal FunctionPharmacological Study	2011	39
Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro. C.B. Caputo, Linda A. Sygowski, Donald J. Wolanin, Journal of Pharmacology and Experimental Therapeutics	1987	31
Pharmacological Characterization of ZD6021: A Novel, Orally Active Antagonist of the Tachykinin Receptors William L. Rumsey, David Aharony, Russell Bialecki, Journal of Pharmacology and Experimental Therapeutics	2001	30
A Nonimmunosuppressive Triene-Modified Rapamycin Analog Is a Potent Inhibitor of Peptidyl Prolyl cis-trans-Isomerase Timothy D. Ocain, Daniel Angelo Longhi, Robert J. Steffan, Biochemical and Biophysical Research Communications Medicinal ChemistryPeptidyl Prolyl Cis-trans-isomeraseBiochemistryPotent InhibitorMedicine	1993	26
Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cells Gavin Lewis, Robert Caccese, Richard J. Heaslip, Inflammation Research InflammationCytokineSignal TransductionHuman Jurkat CellsCell Regulation	1993	21

Page 1